Table 15.
NDMA + NDEA | Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) |
---|---|---|---|---|---|---|
Mean exposure | 0.2–1.4 | 1.2–3.5 | 0.3–2.6 | 0.4–2.1 | 0.6–1.7 | 0.5–1.2 |
MoE | 12,800–90,000 | 5,100–15,000 | 6,900–60,000 | 8,600–45,000 | 10,600–30,000 | 15,000–36,000 |
High level exposure | 0.5–5.8 | 5.0–8.3 | 1.6–7.3 | 1.4–6.3 | 1.9–5.1 | 1.5–3.1 |
MoE | 3,100–36,000 | 2,200–3,600 | 2,500–11,200 | 2,800–12,800 | 3,500–9,500 | 5,800–12,000 |
* Based on a BMDL10 of 0.018 mg/kg bw (for NDEA).